glp-1 receptor in brain agonists show promise treating substance use disorders Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis,

Shapsis make it easy to start your journey from home

Djaknu CF, Holst JJ

compounding pharmacies Direct-to-patient delivery with secure packaging Educational materials on peptide therapy, lifestyle enhancement, and treatment expectations We are observing significant clinical interest in how peptide therapies such as sermorelin can enhance GLP-1 treatment plans

I was asked all the right questions and got to provide a full medical history. From there, Sean was matched with a provider who made him feel confident in the treatment plan

Potential benefits: Research shows that tirzepatide leads to greater weight loss than semaglutidelikely because the two hormone mimickers work together for greater effects

2 Department of Endocrinology, SANKO University Faculty of Medicine, Gaziantep, Turkey Correspondence: Nimet Ylmaz, Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey, Email [email protected] Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP receptor agonists are highly effective agents for the treatment of type 2 diabetes and obesity